<DOC>
	<DOCNO>NCT02536378</DOCNO>
	<brief_summary>The ROADSTER 2 Study intend evaluate real world usage ENROUTE Transcarotid Stent use ENROUTE Transcarotid Neuroprotection System physicians vary experience transcarotid technique .</brief_summary>
	<brief_title>POST-APPROVAL STUDY TRANSCAROTID ARTERY REVASCULARIZATION PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE</brief_title>
	<detailed_description />
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Patient must meet one follow criterion regard neurological symptom status degree stenosis : Symptomatic : Stenosis must ≥ 50 % determined angiogram patient history stroke ( minor nondisabling ) , TIA and/or amaurosis fugax within 180 day procedure ipsilateral carotid artery stented . OR Asymptomatic : Stenosis must ≥ 80 % determine angiogram without neurological symptom within prior 180 day . 2 . Target vessel must meet requirement ENROUTE Transcarotid Neuroprotection System ENROUTE Stent System ( refer IFU requirement ) . 3 . Patient discrete lesion locate internal carotid artery ( ICA ) without involvement contiguous common carotid artery ( CCA ) . 4 . Patient ≥ 18 year age . 5 . Patient understands nature procedure provide sign informed consent use form review approved Institutional Review Board/Ethics Committee respective clinical site prior procedure . This obtain prior participation study . 6 . Patient willing comply protocol requirement return treatment center require clinical evaluation . 7 . Patient must life expectancy ≥ 3 year time index procedure without contingency relate medical , surgical endovascular intervention . 8 . Patient meet least one surgical highrisk criterion list . Anatomic High Risk A. Contralateral carotid artery occlusion B. Tandem stenoses &gt; 70 % C. High cervical carotid artery stenosis D. Restenosis carotid endarterectomy E. Bilateral carotid artery stenosis require treatment within 30 day index treatment . F. Hostile Necks Investigator deem safe transcarotid access include limited : I . Prior neck irradiation II . Radical neck dissection III . Cervical spine immobility Clinical High Risk G. Patient ≥ 75 year age H. Patient ≥ 2vessel coronary artery disease history angina severity I . Patient history angina Canadian Cardiovascular Society ( CCS ) angina class 3 4 unstable angina J . Patient congestive heart failure ( CHF ) New York Heart Association ( NYHA ) Functional Class III IV K. Patient know severe leave ventricular dysfunction LVEF &lt; 30 % . L. Patient myocardial infarction &gt; 72 hour &lt; 6 week prior procedure . M. Patient severe pulmonary disease ( COPD ) either : FEV1 &lt; 50 % predict chronic oxygen therapy rest PO2 &lt; 60 mmHg ( room air ) N. Patient permanent contralateral cranial nerve injury O . Patient chronic renal insufficiency ( serum creatinine &gt; 2.5 mg/dL ) . NOTE : Anatomy render transfemoral CAS hazardous also include ROADSTER 2 Study . I. TypeII , III , Bovine arch II . Arch atheroma calcification III . Atheroma great vessel origins IV . Tortuous distal ICA V. Tortuous occlude iliofemoral segment VI . Occluded aortoiliac segment EXCLUSION CRITERIA : Each potential patient must screen ensure meet follow exclusion criterion . This screening base know medical history data available time eligibility determination enrollment . 1 . Patient alternative source cerebral embolus , include limited : 1 . Patient chronic atrial fibrillation . 2 . Patient episode paroxysmal atrial fibrillation within past 6 month , history paroxysmal atrial fibrillation require chronic anticoagulation . 3 . Knowledge cardiac source emboli . e.g . leave ventricular aneurysm , intracardiac filling defect , cardiomyopathy , aortic mitral prosthetic heart valve , calcific aortic stenosis , endocarditis , mitral stenosis , atrial septal defect , atrial septal aneurysm , leave atrial myxoma ) . 4 . Recently ( &lt; 60 day ) implant heart valve ( either surgically endovascularly ) , know source embolus confirm echocardiogram . 5 . Abnormal angiographic finding : ipsilateral intracranial extracranial arterial stenosis great severity lesion treat , cerebral aneurysm &gt; 5 mm , AVM ( arteriovenous malformation ) cerebral vasculature , abnormal angiographic finding . 2 . Patient history spontaneous intracranial hemorrhage within past 12 month , recent ( &lt; 7 day ) stroke sufficient size ( CT MRI ) place risk hemorrhagic conversion procedure . 3 . Patient evolve stroke . 4 . Patient severe dementia . 5 . Patient CABG , endovascular stent procedure , valve intervention vascular surgery within 30 day intervention . 6 . Myocardial Infarction within 72 hour prior intervention . 7 . Presence previous place intravascular stent target vessel ipsilateral CCA significant CCA inflow lesion . 8 . Occlusion [ Thrombolysis In Myocardial Infarction Trial ( TIMI 0 ) ] `` string sign '' &gt; 1cm ipsilateral common internal carotid artery . 9 . An intraluminal filling defect ( defined endoluminal lucency surround contrast , see multiple angiographic projection , absence angiographic evidence calcification ) associate ulcerated target lesion . 10 . Patient TIA amaurosis fugax within 48 hrs prior procedure . 11 . Patient isolate hemisphere . 12 . Patient open stoma neck . 13 . Female patient pregnant may become pregnant . 14 . Patient history intolerance allergic reaction study medication stent material ( refer stent IFU ) , include aspirin ( ASA ) , ticlopidine , clopidogrel , statin contrast medium ( ca n't pre medicate ) . Patients must able tolerate statin combination ASA ticlopidine ASA clopidogrel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>